Wenmei Su

1.5k total citations
45 papers, 1.1k citations indexed

About

Wenmei Su is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenmei Su has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 26 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenmei Su's work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (16 papers) and Circular RNAs in diseases (9 papers). Wenmei Su is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (16 papers) and Circular RNAs in diseases (9 papers). Wenmei Su collaborates with scholars based in China, United States and Finland. Wenmei Su's co-authors include Jiayuan Wu, Manyu Chen, Caixia Liang, Guoan Chen, David G. Beer, Chunfang Guo, Zhuwen Wang, Andrew C. Chang, Xiuyuan Chen and Xia Yang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Wenmei Su

41 papers receiving 1.1k citations

Peers

Wenmei Su
Lihao Zhao China
Dakui Luo China
Yun Che China
Pu Li China
Mahito Miyamae Japan
Tianan Guo China
Taisuke Imamura Japan
Yunxiao Meng China
Lihao Zhao China
Wenmei Su
Citations per year, relative to Wenmei Su Wenmei Su (= 1×) peers Lihao Zhao

Countries citing papers authored by Wenmei Su

Since Specialization
Citations

This map shows the geographic impact of Wenmei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmei Su more than expected).

Fields of papers citing papers by Wenmei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmei Su. The network helps show where Wenmei Su may publish in the future.

Co-authorship network of co-authors of Wenmei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmei Su. A scholar is included among the top collaborators of Wenmei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmei Su. Wenmei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xincheng, Wenmei Su, Qingyu Wang, et al.. (2025). Akkermansia muciniphila inhibits jejunal lipid absorption and regulates jejunal core bacteria. Microbiological Research. 293. 128053–128053. 1 indexed citations
2.
Chen, Wei, Weijun Zhao, Ziyuan Chen, et al.. (2025). circFOXK2 Stabilizes STMN1 mRNA via PABPC1 to Promote the Progression of NSCLC. Cancer Medicine. 14(5). e70729–e70729. 2 indexed citations
3.
Pang, Ming, et al.. (2025). IGF2BP3-regulated circPLEKHH2 promotes autophagy via AKT/mTOR signaling pathway to suppress lung adenocarcinoma progression. International Journal of Biological Macromolecules. 315(Pt 2). 144262–144262.
4.
5.
Huang, Qiang, et al.. (2025). A bibliometric analysis of artificial intelligence applied to cervical cancer. Frontiers in Medicine. 12. 1562818–1562818. 1 indexed citations
6.
Huang, Xiaobi, Xiaofang Li, Yongyang Chen, et al.. (2024). Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A. Discover Oncology. 15(1). 3–3. 5 indexed citations
7.
Liu, Chang, Yongyang Chen, Xiaoyu Xu, et al.. (2024). Utilizing Macrophages Missile for Sulfate-Based Nanomedicine Delivery in Lung Cancer Therapy. Research. 7. 448–448. 7 indexed citations
8.
Chen, Yongyang, Xiaobi Huang, Lihui Wang, et al.. (2023). Circular RNA‐mediated ceRNA network was identified in human lung adenocarcinoma by high‐throughput sequencing. Thoracic Cancer. 14(16). 1430–1439. 4 indexed citations
9.
10.
Bai, Lu, Wenmei Su, Chaoqun Chen, et al.. (2022). Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO. Frontiers in Pharmacology. 13. 1007006–1007006. 3 indexed citations
11.
Liang, Yingying, Xiaoyan Liu, Guoan Chen, et al.. (2021). LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB. Journal of Gastrointestinal Oncology. 12(6). 2622–2630. 7 indexed citations
12.
Chen, Hualin, Meilian Liu, Zhiwei Dai, et al.. (2020). Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma. Translational Lung Cancer Research. 9(4). 1225–1234. 13 indexed citations
13.
Huang, Zhong, et al.. (2020). <p>The Clinical Characteristics and Prognosis of Different Age Patients with Lung Cancer</p>. Cancer Management and Research. Volume 12. 8445–8450. 2 indexed citations
14.
Xia, Yang, Wenmei Su, Xiuyuan Chen, et al.. (2019). Validation of a serum 4-microRNA signature for the detection of lung cancer. Translational Lung Cancer Research. 8(5). 636–648. 19 indexed citations
15.
Su, Wenmei, Xiuyuan Chen, Xia Yang, et al.. (2018). Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer. Cancer Research. 78(12). 3207–3219. 119 indexed citations
16.
Wu, Jiayuan, Gaohua Zhang, Yufeng Wang, et al.. (2018). Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis. Cellular Physiology and Biochemistry. 51(2). 575–588. 18 indexed citations
17.
Zhang, Jie, Wenmei Su, Lei Xiao, et al.. (2017). Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Scientific Reports. 7(1). 42819–42819. 43 indexed citations
18.
Su, Wenmei, et al.. (2016). miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1. Biomedicine & Pharmacotherapy. 84. 123–129. 42 indexed citations
19.
Su, Wenmei, Liang Luo, Xiaofang Li, et al.. (2015). Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non–small cell lung cancer. Human Pathology. 46(5). 732–738. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihao Zhao Breakdown of academic impact, for papers by Dakui Luo Breakdown of academic impact, for papers by Yun Che Breakdown of academic impact, for papers by Pu Li Breakdown of academic impact, for papers by Mahito Miyamae Breakdown of academic impact, for papers by Tianan Guo Breakdown of academic impact, for papers by Taisuke Imamura Breakdown of academic impact, for papers by Yunxiao Meng
Rankless by CCL
2026